Patents
Patents for C07K - Peptides (3,738)
12/2006
12/06/2006EP1587820A4 Isoform specific interactions of apolipoprotein e to an intermediate conformation of alzheimer a beta peptide
12/05/2006US7144895 Benzene acetamide compounds useful as serine protease inhibitors
11/2006
11/30/2006US20060270839 Crystallization of IGF-1
11/30/2006US20060270829 G-csf conjugates
11/30/2006US20060270703 G-csf conjugates
11/29/2006EP1540015A4 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
11/29/2006CN1871022A Peptides and compounds that bind to a receptor
11/29/2006CN1871020A Antagonistic analogs of GH-RH (2003)
11/29/2006CN1869068A Corticotropin releasing factor 2 receptor agonists
11/29/2006CN1869061A Peptidomimetic protease inhibitors
11/28/2006US7141596 Inhibitors of proteins that bind phosphorylated molecules
11/23/2006US20060263864 Methods for improving secondary metabolite production of fungi
11/22/2006EP1722822A1 New complexes
11/22/2006EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/21/2006US7138120 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
11/16/2006US20060257980 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
11/15/2006EP1615996A4 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
11/09/2006WO2004094454A3 Hla-a2 tumor associated antigen peptides and compositions
11/09/2006US20060252129 Human coagulation Factor VII variants
11/09/2006US20060251580 Lectin conjugates
11/08/2006CN1283659C Truncated glial cell line-derived neurotrophic factor
11/07/2006US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/02/2006WO2005049638A3 Amniotic-derived peptide and uses thereof
11/02/2006US20060246104 Stable rgd peptidomimetic composition
11/01/2006CN1856476A Isoquinolinone potassium channel inhibitors
11/01/2006CN1856470A 喹啉钾通道抑制剂 Quinoline potassium channel inhibitors
10/2006
10/26/2006WO2005058940A3 Immunogenic peptide carrier conjugates and methods of producing same
10/26/2006WO2005056578A9 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers
10/26/2006US20060241024 Intermediate for preparing glycopeptide derivatives
10/26/2006US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006US20060240517 Novel receptor nucleic acids and polypeptides
10/25/2006EP1715045A2 Recombinant antibodies for human therapy
10/25/2006CN1852919A Agonist polypeptide of receptor for ZOT and zonulin
10/19/2006US20060234209 Microchip-based system for hiv diagnostics
10/19/2006US20060233746 N-terminally chemically modified protein compositions and methods
10/17/2006US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006US7122521 Collagen mimics
10/17/2006US7122372 Peptide useful in immunomodulation
10/12/2006WO2005042561A3 Neural regeneration peptides and methods of use
10/12/2006US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity
10/11/2006CN1846000A HPV CD8+ T-cell epitopes
10/10/2006US7119080 Boronic ester and acid compounds, synthesis and uses
10/04/2006EP1706513A2 Human immunodeficiency virus entry inhibitor assay
10/04/2006EP1706131A2 Helical synthetic peptides that stimulate cellular cholesterol efflux
10/04/2006CN1840178A Tumour-specific animal proteins
10/03/2006US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders
10/03/2006US7115266 Angiotensin peptide-carrier conjugates and uses thereof
09/2006
09/28/2006WO2005037853A3 Side chain deuterated amino acids and methods of use
09/28/2006US20060217300 Analogues of glp-1
09/28/2006US20060216778 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides
09/28/2006US20060216716 Immunologic activity measures for t helper on-associated conditions
09/28/2006US20060216299 Cell cycle targets and peptides
09/26/2006US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto
09/21/2006WO2005047308A3 Peptide-based diagnostic reagents for sars
09/21/2006US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides
09/20/2006EP1701968A2 Immunogenic peptide carrier conjugates and methods of producing same
09/20/2006EP1701730A2 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
09/20/2006CN1835763A CCN1 compositions and methods
09/14/2006WO2005021583A8 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β
09/14/2006US20060205927 Templated native silk smectic gels
09/14/2006US20060205671 Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
09/14/2006US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases
09/13/2006EP1699810A2 A beta immunogenic peptide carrier conjugates and methods of producing same
09/13/2006EP1699809A2 Amniotic-derived peptide and uses thereof
09/08/2006WO2005035551A3 Inhibitors of proteins that bind phosphorylated molecules
09/06/2006EP1697399A2 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
09/06/2006EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
09/06/2006EP1620726A4 Polypeptides related to natriuretic peptides and methods of their identification and use
09/06/2006EP1616181A4 Polypeptides related to natriuretic peptides and methods of their identification and use
09/05/2006US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity
09/05/2006US7101689 Interleukin-18 binding proteins, their preparation and use
08/2006
08/31/2006WO2006024694A3 Peptide inhibitors of hk2 and their use
08/30/2006EP1694349A2 Integrin alpha ii beta3 specific antibodies and peptides
08/30/2006CN1826137A Inducible ligand for alpha1beta1 integrin and uses
08/24/2006WO2005051973A3 Peptides derived from natural cytotoxicity receptors and methods of use thereof
08/24/2006US20060188884 for use in second generation HIV vaccines and as diagnostic tools in the treatment and control of HIV infection; define a critical balance between MHC affinity and receptor crossreactivity required for effective epitope enhancement and also demonstrate construction and efficacy of
08/23/2006EP1692505A2 Cd4+ epitopes of bone morphogenetic proteins
08/23/2006EP1691822A2 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers
08/23/2006EP1691818A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
08/23/2006CN1821226A Antipicornaviral compounds, their preparation and use
08/17/2006WO2005040196A3 Pif peptides biologic activities, site of action, and the antibody to detect pif
08/17/2006US20060183156 PrPSc-selective peptides
08/16/2006CN1817906A Antibody against human parathormone related peptides
08/15/2006US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder
08/10/2006WO2006083276A2 Interferon-alpha polypeptides and conjugates
08/10/2006US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
08/09/2006EP1687318A2 New coupling agents for peptide synthesis
08/09/2006CN1816563A Polypeptides having binding affinity for HER2
08/03/2006US20060172931 Heparin-binding peptides and uses thereof
08/03/2006US20060171885 Skin or hair binding peptides
08/02/2006EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine
08/02/2006EP1685151A2 Neural regeneration peptides and methods for their use in treatment of brain damage
08/02/2006EP1684789A2 Mammalian t1r3 sweet taste receptors
08/02/2006EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine
08/02/2006CN1813187A Nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/02/2006CN1812804A Selective r-cadherin antagonist and methods
08/01/2006US7084252 receptor for a satiety factor, which is involved in body weight homeostasis
08/01/2006US7084240 Crystallization of IGF-1
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 38